Read the latest news about what we’ve achieved together.
Research in focus
Our Research in focus reports give an overview of an aspect of CF where our funding is making a difference. Read our Research in focus report on CF-related diabetes, published in June 2020.
Advancing knowledge of CF and how to treat it
Every research study that the Trust has funded builds on what we know about CF, how it affects people and what might be the best way to treat it. We’ve divided our research into three topics, and for each of them we’ve described in detail how our research has contributed to what we know today about cystic fibrosis.
Tackling the underlying cause of cystic fibrosis
We have funded research with a range of strategies to tackle the underlying cause of the disease. These include methods to deliver healthy copies of the CF gene, repair the damaged CF gene itself or to boost the activity of ‘alternative’ channel proteins.
Read more about the achievements of our research projects investigating the underlying cause of CF
Understanding and treating symptoms of cystic fibrosis
Our research funding has supported new ways to monitor lung health and high-risk pharmaceutical development pipelines. In 2017 we learned the results of a project at Nottingham University to understand the CF community’s priorities for research, it has become one of the guiding principles on deciding which research projects we fund.
Read more about the achievements of our research projects understanding and treating symptoms of CF
Understanding and treating lung infections
Research funded by the Trust has led to the development of new guidelines for managing NTM cross infection, a bank of clinical Pseudomonas samples that accurately represent the infection in people with CF, and a better understanding of how the bugs adapt to the CF lung.
Read more about the achievements of our research projects towards a better understanding and better treatments for lung infections
Looking back at achievements from our 2013–2018 research strategy
When the Trust’s first five-year research strategy drew to a close in 2018, we analysed our performance in delivering the programme we set out to achieve. We delivered on the majority of our objectives and the findings helped to shape our current strategy. Read more about the analysis.